Back to Journals » OncoTargets and Therapy » Volume 17

LncRNA WT1-AS/mir-494-3P Regulates Cell Proliferation, Apoptosis, Migration and Invasion via PTEN/PI3K/AKT Signaling Pathway In Non-Small Cell Lung Cancer [Retraction]

Authors Wu C, Yang J, Li R, Lin X, Wu J, Wu J

Received 4 September 2024

Accepted for publication 4 September 2024

Published 6 September 2024 Volume 2024:17 Pages 739—740

DOI https://doi.org/10.2147/OTT.S494633



Wu C, Yang J, Li R, Lin X, Wu J, Wu J. OncoTargets and Therapy 2021;14:891–904

We, the Editor and Publisher of the journal OncoTargets and Therapy have retracted the published article.

Following publication, concerns were raised regarding the duplication of images from Figure 3C with images from an unrelated article. Specifically,

  • Images for Figure 3C, NCI-H1975, OverExp-NC, have been duplicated with images for Figure 2f, Control, from Zhu, D., Shi, C., Jiang, Y., Zhu, K., Wang, X., & Feng, W. (2021). Cisatracurium inhibits the growth and induces apoptosis of ovarian cancer cells by promoting lincRNA-p21. Bioengineered, 12(1), 1505–1516. https://doi.org/10.1080/21655979.2021.1916271.

The corresponding author did not respond to our queries and was unable to provide a satisfactory explanation for how the images came to be duplicated or provide satisfactory original data for the study. As verifying the validity of published work is core to the integrity of the scholarly record, the Publisher and Editor requested to retract the article and the corresponding author was notified of this decision.

We have been informed in our decision-making by our editorial policies and COPE guidelines.

The retracted article will remain online to maintain the scholarly record, but it will be digitally watermarked on each page as “Retracted”.


This retraction relates to this paper


Creative Commons License © 2024 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, 3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.